In-vivo proof of concept in malignant melanoma - PR Inside
LU Bio portfolio company Cantargia has achieved in-vivo proof of concept targeting IL1RAP expressing human tumor. The concept of targeting IL1RAP has with these findings been further validated. The results show highly significant inhibition of tumor growth ...
Rugby team strips off in aid of cancer charity calendar (From The Bolton News) - The Bolton News
Members of Bolton RUFC shed their kits during December’s cold weather to pose for pictures in aid of Factor 50, the malignant melanoma support group attached to The Christie Hospital. The club in Avenue Street, Bolton, has taken part in the calendar to ...
Save Your Skin Foundation - Market Wire
This news hits a personal note for Barnard, who is fighting her own battle with melanoma. In 2003 Barnard was first diagnosed, and by 2005 stage IV malignant melanoma had spread. Tumors were found in her left lung, kidney, liver, and adrenal gland.
One Woman's Experience As A Clinical Trial 'Lab Rat' - NPR News
A year after recovering from malignant melanoma, Salon.com writer Mary Elizabeth Williams found out it had returned in the form of metastatic, Stage 4 cancer. In October 2011, she started a clinical trial for a new melanoma drug. Halfway through ...
Karmanos researcher takes co-lead in national skin cancer study - Crain's Detroit Business
Karmanos added that women who use tanning beds more than once a month are 55 percent more likely to develop malignant melanoma, the most deadly form of skin cancer. In 2008, Michigan passed a bill that requires parental consent for anyone under ...
Molecular Switch That Allows Melanoma to Resist Therapy Identified - Med India
TF2 is a two-faced protein—in melanoma cells, it's oncogenic, or cancer-causing, while in non-malignant types of skin cancers, it acts as a tumor suppressor. In a paper published February 3 in the journal Cell. This switch is controlled by ...
Scientists identify molecular switch that controls ATF2's dual functions - News-Medical.Net
ATF2 is a two-faced protein-in melanoma cells, it's oncogenic, or cancer-causing, while in non-malignant types of skin cancers, it acts as a tumor suppressor. In a paper published February 3 in the journal Cell, the team identified a molecular ...
Skin cancer prevention - Examiner
In Australia the rate of skin cancers which including Basal cell carcinomas, squamous cell carcinomas and malignant melanoma. Malignant melanoma is dark and sometimes resembles a mole, bleeding, itching, change in color, size and shape are clues that a ...
Thomas Clasen formerly of West Redding - Amity Observer
Thomas Clasen, 55, of Plant City, Fla., formerly of West Redding, died on Friday, Jan. 20, 2012 of metastatic malignant melanoma (diagnosed in July 2011). His sister, Suzanne (Clasen) Kinnear and her husband Larry Kinnear, of Bethel were at his side at the ...
Survey Awards